A Review on Biological Activity of Heterocyclic Nucleus Carbazole
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder associated with cognitive deterioration affecting day to day living and behavioural activities. It is commonest cause of senile and pre-senile dementia. In Alzheimer’s disease, a peptide referred as amyloid beta aggregates (oligomers), and accumulates in the brain to form deposits called as amyloid plaques. According to the world health organization (WHO), 5% of men and 6% of women of above 60 years are victims with Alzheimer’s type dementia globally. In India prevalence of dementia is 33.6%, of which AD contributes approximately 54% and vascular dementia constitutes approximately 39%. Patients with the prolonged use of some Non-steroidal anti-inflammatory (NSAID) drugs such as ibuprofen have lower risk of developing the symptoms of AD; however the chronic use of NSAID can produce a toxic effect on the kidney, liver and GI tract. Recent studies have demonstrated that a curcumin delivery system based on nanoscience and nanotechnology increases the therapeutic potential of this compound. Specifically, several nano-sized carriers such as phospholipid vesicles (liposomes), micelles, solid lipid nanoparticles, polymeric nanoparticles, emulsions, proteins and other molecular complexes have been developed for the efficient delivery of curcumin. Nano particles have demonstrated the enhanced Bioavailability of curcumin including circulation time in the blood. Various nano technology drug delivery system of curcumin showed increased Bio accessibility during treatment of Alzheimer’s disease.
2. Asche, C. et. al. Synthesis-activity relationship of 5H-benzo[b]carbazoles. Bioorganic and Medicinal Chemistry, 2005; 13:819-837.
3. Barbieri, V. et. al. Microwave-assisted one-pot synthesis of substituted tetrahydrocarbazole and 8, 9, 10, 11-tetrahydro-7H-pyrido[α]carbazoles. Tetrahedron Letters, 2006; 47:8289-8292
4. Barta, T.E. et. al., Novel carbazole and acyl-indole anti-mitotics. Bioorganic and Medicinal Chemistry, 2009; 19:3078-3080.
5. Baumann, S. et. al. NSAID-derived γ-secretase modulators. Part III: Membrane anchoring. Bioorganic and Medicinal Chemistry Letters, 2009; 19:6986-6990.
6. Becknell, N.C. et. al. Novel C-3 N-urea, amide, and carbamatedihydroindazolo[5,4-α]pyrrolo[3,4-c]carbazoleanalogs as potent TIE-2 and VEGF-R2 dual inhibitors. Bioorganic and Medicinal Chemistry, 2006; 16:536.
7. Bedford, R.B. et. al. N-H Carbazole synthesis from 2-chloroanilines via consecutive amination and C-H activation. Journal of Organic Chemistry, 2006; 71:9403-9410.
8. Bedford, R.B. et. al. Intramolecular direct arylation in the synthesis of fluorinated carbazoles. Tetrahedron, 2008; 64:6038-6050.
9. Bergman, J.et. al.Synthesis of carbazole alkaloids. Pure & Applied Chemistry, 1990; 62(10):1967-1976.
10. Bianchi L. et. al.An original route to newly-functionalized indoles and carbazoles starting from the ring-opening of nitrothiophenes. Tetrahedron Letters, 2012; 53:752-757.
11. Nadia Salihet. al. Synthesis and antimicrobial activities of 9H-carbazole derivatives, Arabian Journal of Chemistry, 2016; 9:S781–S786.
12. Ahmad H. Abdullah et.al. Synthesis and antibacterial activity of N1- (carbazol-3-yl)amidrazones incorporating piperazines and related congeners, Z. Naturforsch. 2016; 71(8)b;857–867
13. Entesar M. Ahmed et.al. Towards breast cancer targeting: Synthesis of tetrahydroindolocarbazoles, antibreast cancer evaluation, uPA inhibition, molecular genetics and molecular modelling studies, Bioorganic Chemistry, 2019; 93:103332
14. Pramod V. Chavan et.al. Click chemistry based multicomponent approach in the synthesis of spirochromenocarbazole tethered 1,2,3-triazoles as potential anticancer Agents, Bioorganic Chemistry , 2019; 85:475–486
15. Peng-Hui Li et. al. Synthesis of carbazole derivatives containing chalconeanalogs as non-intercalative topoisomerase II catalytic inhibitors and apoptosis Inducers, European Journal of Medicinal Chemistry, 2018; 145:498-510
16. aGng Li et. al. One-step synthesis of methylene-bridged bis-carbazole and evaluation of its antitumor activity and G-quadruplex DNA binding property, Bioorganic Chemistry, 2019; 90:103074
17. Karunanidhi Murali et.al. Synthesis of hetero annulated isoxazolo-, pyrido- and pyrimidocarbazoles: Screened for in vitro antitumor activity and structure activity relationships, A novel 2-amino-4-(3'-bromo- 4'-methoxyphenyl)-8-chloro-11H-pyrimido[4,5-a]carbazole as an antitumor, European Journal of Medicinal Chemistry, 2017; 30071(5):S0223-5234
18. KarunanidhiMurali et.al. Regioselective synthesis and stereochemical structure of anti-proliferative active dispirooxindole-pyrrolo-carbazole hybrids via 1,3-dipolar cycloaddition reactions, European Journal of Medicinal Chemistry, 2017; 30942-X:S0223-5234
19. Takashi Nishiyama et.al. Concise synthesis of carbazole-1,4-quinones and evaluation of theirantiproliferative activity against HCT-116 and HL-60 cells, European Journal of Medicinal Chemistry, 2016; 121:561-577
20. PerumalSathiyachandranet. al. Design and synthesis of novel pyrrolo[2,3-a]carbazoles: 7-Chloro-2-oxo-3a-(2'-oxo-2',3'- dihydro-1'H-indol-3'-yl)-2,3,3a,4,5,10-hexahydro-pyrrolo[3,2-a]carbazole-1-carbonitrile as an efficient anticancer agent, , European Journal of Medicinal Chemistry, 2018; 30299-X:S0223-5234
21. Lianqi Sun et. al. Novel CarbazoleSulfonamide Derivatives of Antitumor Agent: Synthesis, Antiproliferative Activity and Aqueous Solubility, Bioorganic & Medicinal Chemistry Letters, 2016; S0960-894X:31214-8
22. ShaziaIqbal et.al. New carbazole linked 1,2,3-triazoles as highly potent non-sugar a-glucosidase inhibitors, Bioorganic Chemistry, 2017; 74:72–81
23. Ji-Quan Zhang et. al. Discovery of tetrahydrocarbazoles with potent hypoglycemic and hypolipemic Activities, European Journal of Medicinal Chemistry, 2018; 30206-X:S0223-5234
24. CarstenBörgeret. al. Anti-tuberculosis activity and structure–activity relationships of oxygenated tricyclic carbazole alkaloids and synthetic derivatives, Bioorganic & Medicinal Chemistry, 2017; 25:6167–6174
25. GerasimosRassiaset. al. Cell-active carbazole derivatives as inhibitors of the zika virus Protease, , European Journal of Medicinal Chemistry, 2019; 180:536-545
26. RoshanakGhobadianet. al. Novel tetrahydrocarbazole benzyl pyridine hybrids as potent and selective butryl cholinesterase inhibitors with neuroprotective and β-secretase inhibition activities, , European Journal of Medicinal Chemistry, 2018; 30444-6:S0223-5234
27. Weisi Wang et. al. Novel carbazoleamino alcohols as inhibitors of b-hematin formation: Anti-plasmodial and anti-schistosomal activities, International Journal for Parasitology: Drugs and Drug Resistance , 2017:191-199.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).